Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Vasogen completes patient enrollment in congestive heart failure trial

June 27, 2001

Mechanism of blood pressure-lowering effects of PPARgamma agonists studied using GW-1929

June 26, 2001

Sphingomyelinase inhibitors discovered in natural sources at Kitasato Institute

June 25, 2001

Results for Vasogen's immune modulation therapy to be presented in September

June 25, 2001

Nortran's antiarrhythmic agent shows oral bioavailability

June 25, 2001

Vasopressin antagonists reported by Ortho-McNeil in patent literature

June 22, 2001

Numerous studies published recently on soon-to-be-introduced ARB olmesartan

June 22, 2001

PROGRESS trials show Aceon/diuretic combination reduces recurrent stroke by 50%

June 22, 2001

Grupo Vita uses Spain as reference member state for approval of enalapril/nitrendipine

June 21, 2001

Role of calcineurin in cardiac hypertrophy and subsequent heart failure

June 20, 2001

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...